On September 12, 2022, Del. Michelle Maldonado and John Newby, CEO of Virginia Bio, welcomed participants to a legislative briefing on the transformative potential of gene therapies on rare disease.
Read MoreOn September 12, 2022, Del. Michelle Maldonado and John Newby, CEO of Virginia Bio, welcomed participants to a legislative briefing on the transformative potential of gene therapies on rare disease.
Read More